Nanobots in Lung Cancer Therapy: An Overview
DOI:
https://doi.org/10.67224/ioasdjmps.2026.v03i03.007Keywords:
Lung Cancer; Nanoparticles; Nanobots; Synthetic, Biohybrid, DNA Origami Systems; TheranosticsAbstract
Lung cancer remains the leading cause of cancer related death worldwide. It is responsible for roughly 18.4% of all cancer deaths [1]. Late-stage diagnosis, drug resistance and the limitation of getting a therapeutic agent precisely to the lung tumor site continues to be major drawbacks. Nanoparticle based drug delivery has advantages toward solving this problem due to its tiny size, distribution and precise absorption in tumor site. Such tumor targeting improves bioavailability. ‘Nanorobots’ or ‘Nanobots’ are nanoscale devices function on autonomous or semi-autonomous principle and capable of navigating through biological environment to exhibit programmable drug release at the targeted site. This review provides a broad overview of the major classes of nanobots being explored for lung cancer therapy, namely synthetic, biohybrid and DNA origami systems. This piece of the article also attempts to discuss various routes used to administer these nanobots and the mechanisms through which they act on tumors. Their emerging roles in the diagnosis are also considered. Finally, the challenges, limitations and future perspectives were also considered under its purview.
References
1. Carrasco-Esteban, E., Dominguez-Rullan, J. A., Barrionuevo-Castillo, P., Pelari-Mici, L., Leaman, O., Sastre-Gallego, S., & Lopez-Campos, F. (2021). Current role of nanoparticles in the treatment of lung cancer. Journal of Clinical and Translational Research, 7(2), 140-155.
2. Koutu, V., Gupta, M., Das, S., Rawat, D. K., Kharade, V., & Pasricha, R. K. (2023). Nanotechnology in lung cancer therapeutics: A narrative review. Cureus, 15(1), e34245.
3. Sheikh, M., & Jirvankar, P. S. (2024). Harnessing artificial intelligence for enhanced nanoparticle design in precision oncology. AIMS Bioengineering, 11(4), 574-597.
4. Halim, P., Tan, M. W., Yumiko, Lu, F. C., Dalimunthe, A., Tallei, T. E., Rahman, M., Rani, A., Kim, B., Maciel de Azambuja Ribeiro, R. I., & Syahputra, R. A. (2026). Nanotechnology in lung cancer: Enhancing targeted drug delivery and diagnostic precision. Results in Surfaces and Interfaces, 23, Article 100773.
5. Khan, Z., Khan, N., Geetha, M., Veettil, R. P., Kasote, D. M., Hasan, A., & Sadasivuni, K. K. (2025). Therapeutic applications of nanobots and nanocarriers in cancer treatment. Analytical Sciences, 41(8), 1305-1324.
6. Dey, R. K., Jana, B., & Dastidar, D. G. (2023). Applications of nanotechnology in the treatment of pulmonary diseases. Vessel Plus, 7, 17.
7. Subramaniam, S., Donnellan, L., Wignall, A., Woodcock, J., Coolen, C., Pitson, S., Taheri, A., Young, C., Hoffmann, P., Prestidge, C. A., & Joyce, P. (2025). Polymeric-lipid nanoparticles that leverage cationic helper lipids and the protein corona for lung-targeted delivery of a novel anti-cancer drug. Journal of Controlled Release, 388(Part 1), 114299.
8. Pradeep, P., Sonia, M. M. L., & Kizhakkepeedika, R. D. (2024). Nanobots in cancer treatment–Framing lung cancer. Journal of Advanced Lung Health, 4(2), 57-69.
9. Lee, H., Sajid, K., & Lee, J. (2025). Engineered nanocarriers for targeted lung cancer therapy: Mechanistic innovations and recent clinical progress. Exploration of Targeted Anti-tumor Therapy, 6, 1002339.
10. George, M., Boukherroub, R., Sanyal, A., & Szunerits, S. (2025). Treatment of lung diseases via nanoparticles and nanorobots: Are these viable alternatives to overcome current treatments? Materials Today Bio, 31, 101616.
11. Zhang, L., Abbott, J. J., Dong, L., Kratochvil, B. E., Bell, D., & Nelson, B. J. (2009). Artificial bacterial flagella: Fabrication and magnetic control. Applied Physics Letters, 94(6), 064107.
12. Medina-Sanchez, M., Xu, H., & Schmidt, O. G. (2018). Micro- and nanomotors: The new generation of drug carriers. Therapeutic Delivery, 9(4), 303-316.
13. Li, S., Jiang, Q., Liu, S., Zhang, Y., Tian, Y., Song, C., Wang, J., Zou, Y., Anderson, G. J., Han, J. Y., Chang, Y., Liu, Y., Zhang, C., Chen, L., Zhou, G., Nie, G., Yan, H., Ding, B., & Zhao, Y. (2018). A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. Nature Biotechnology, 36(3), 258-264.
14. Gultepe, E., Randhawa, J. S., Kadam, S., Yamanaka, S., Selaru, F. M., Shin, E. J., Kalloo, A. N., & Gracias, D. H. (2013). Biopsy with thermally-responsive untethered microtools. Advanced Materials, 25(4), 514-519.
15. Xu, Y., Bian, Q., Wang, R., & Gao, J. (2022). Micro/nanorobots for precise drug delivery via targeted transport and triggered release: A review. International Journal of Pharmaceutics, 616, 121551.
16. Cardoso, V. M. O., Bistaffa, M. J., & Zucolotto, V. (2025). Nanomedicine innovations for lung cancer diagnosis and therapy. ACS Applied Materials & Interfaces, 17(9), 13197-13220.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ratnamoy Roy, Nilimanka Das (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The IOASD Journal of Medical and Pharmaceutical Sciences publishes all articles under the Creative Commons Attribution–NonCommercial 4.0 International (CC BY-NC 4.0) License. Under this license, readers are free to copy, distribute, share, adapt, and reproduce the published work in any medium or format for non-commercial purposes, provided that appropriate credit is given to the original author(s) and the source.
